Mohammad Azab
Director/Board Member at XENON PHARMACEUTICALS INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Mohammad Magdy Mohamed Azab currently works at Pyramisa Hotels, as Vice Chairman & MD-Financial Affairs, DURECT Corp., as Independent Director, Xenon Pharmaceuticals, Inc., as Independent Director from 2003, Lisata Therapeutics, Inc., as Independent Director from 2022, American Society of Clinical Oncology, Inc., as Member, American Society of Hematology, as Member, European Society for Medical Oncology, as Member, and International Association for the Study of Lung Cancer, as Member.
Dr. Azab also formerly worked at Intradigm Corp., as President, Chief Executive Officer & Director from 2006 to 2010, Astex Pharmaceuticals, Inc., as Chairman from 2020 to 2022, Sernova Corp., as Independent Director from 2021 to 2023, Chemokine Therapeutics Corp., as Director from 2006 to 2007, QLT, Inc., as Chief Medical Officer, EVP-Research & Development from 1997 to 2005, SuperGen, Inc., as Chief Medical Officer from 2009 to 2011, Astex Therapeutics Ltd., as Chief Medical Officer, American Association for Cancer Research, as Member, and Sanofi-Synthelabo, Inc., as Manager-International Medical Oncology from 1989 to 1992.
Dr. Azab received his doctorate degree in 1979 from the University of Cairo, graduate degree from Université de Paris XI Paris Sud, graduate degree from Université Pierre et Marie Curie, and Masters Business Admin degree in 2001 from Richard Ivey School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-18 | 74,225 ( 0.10% ) | 3 M $ | 2024-03-30 | |
| 2024-01-08 | 58,680 ( 0.71% ) | 183 082 $ | 2024-03-30 | |
DURECT CORPORATION
0.02% | 2024-03-25 | 6,000 ( 0.02% ) | 7 260 $ | 2024-03-30 |
SERNOVA CORP.
-.--% | 2023-04-24 | 0 ( -.--% ) | - $ | 2024-03-30 |
Mohammad Azab active positions
| Companies | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Director/Board Member | 2003-09-30 |
| PYRAMISA HOTELS & RESORTS | Director/Board Member | - |
| DURECT CORPORATION | Director/Board Member | 2021-01-03 |
| LISATA THERAPEUTICS, INC. | Director/Board Member | 2022-09-14 |
| International Association for the Study of Lung Cancer | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Corporate Officer/Principal | 2010-05-12 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Former positions of Mohammad Azab
| Companies | Position | End |
|---|---|---|
| SERNOVA CORP. | Director/Board Member | 2023-05-29 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Mohammad Azab
| University of Cairo | Doctorate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| DURECT CORPORATION | Health Technology |
| SERNOVA CORP. | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| PYRAMISA HOTELS & RESORTS | Consumer Services |
| LISATA THERAPEUTICS, INC. | Health Technology |
| Private companies | 14 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
| Université Pierre et Marie Curie | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
| Sanofi-Synthelabo, Inc. | Health Technology |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
| International Association for the Study of Lung Cancer | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
- Stock Market
- Insiders
- Mohammad Azab
